Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Long-term disease control in Knosp grade 4 Cushing's disease using maximal safe resection and early adjuvant radiotherapy.

Created on 14 Nov 2026

Authors

Atsushi Ishida, Kenji Kagawa, Sachiko Tanaka-Mizuno, Hideki Shiramizu, Haruko Yoshimoto, Go Matsuoka, Koji Takano, Shozo Yamada

Published in

Journal of neurosurgery. Pages 1-9. Nov 13, 2026. Epub Nov 13, 2026.

Abstract

Knosp grade 4 Cushing's disease (CD) represents an anatomically extreme and clinically challenging subtype of pituitary neuroendocrine tumor because a lesion extending deeply lateral to the intracavernous internal carotid artery (ICA) is rarely amenable to complete and safe resection via transsphenoidal surgery. Persistent hypercortisolism in CD directly compromises long-term survival, while aggressive lateral cavernous sinus (CS) dissection carries substantial neurovascular risk. Dedicated outcome studies focusing exclusively on Knosp grade 4 CD remain scarce. Therefore, the authors evaluated the long-term outcomes of a treatment strategy combining maximal safe resection with early adjuvant radiotherapy (RT) for residual CS disease while intentionally avoiding excessively aggressive lateral CS dissection beyond the ICA.
The authors retrospectively reviewed the records of consecutive patients with biochemically confirmed CD and Knosp grade 4 CS invasion treated between 2009 and 2025. The surgical strategy prioritized maximal safe tumor resection while avoiding excessively aggressive dissection lateral to the ICA. Early adjuvant stereotactic RT was administered for residual lateral CS disease. Clinical, endocrinological, and radiological outcomes were analyzed during long-term follow-up, and factors potentially associated with poor disease control were explored.
Thirty patients were included in the analysis. Endocrinological and radiological disease control was achieved in 26 (87%) of them during a mean follow-up of 70.5 months. Tumor progression occurred in 4 patients, all of whom demonstrated persistent hypercortisolism, and 3 subsequently died of disease-related causes. Prior RT exposure and an elevated Ki-67 labeling index were associated with poorer disease control despite multimodal treatment including temozolomide. In contrast, durable endocrine control was achieved in all Crooke cell adenoma cases under the described treatment strategy. No patient experienced ICA injury or disabling cranial neuropathy attributable to aggressive lateral CS dissection.
For Knosp grade 4 CD, durable endocrine control must be balanced against the risks of radical CS surgery. Maximal safe resection combined with early adjuvant RT for residual CS disease provided favorable long-term disease control while avoiding major surgical morbidity. These findings support planned early adjuvant RT as a reasonable strategy for residual lateral CS disease in this rare and anatomically extreme subtype.

PMID:
43024870
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement